Trivedi, Sumita <br/><br/>
Anti-EGFR Targeted Monoclonal Antibody Isotype Influences Antitumor Cellular Immunity in Head and Neck Cancer Patients.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Nov 2016 
 - 5229-5237 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-15-2971  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--immunology<br/>CD8-Positive T-Lymphocytes--drug effects<br/>Carcinoma, Squamous Cell--drug therapy<br/>Cetuximab--immunology<br/>Dendritic Cells--drug effects<br/>ErbB Receptors--antagonists & inhibitors<br/>Head and Neck Neoplasms--drug therapy<br/>Humans<br/>Immunity, Cellular--drug effects<br/>Immunoglobulin G--immunology<br/>Killer Cells, Natural--drug effects<br/>Monocytes--drug effects<br/>Panitumumab<br/>Receptors, IgG--immunology<br/>Squamous Cell Carcinoma of Head and Neck<br/>T-Lymphocytes, Cytotoxic--drug effects